transitional cell carcinoma of bladder Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadtransitional cell carcinoma

I am/have/hadbladder cancer

I am/have/hadcarcinoma

I am/have/hadtransurethral resection

I am/have/hadbladder carcinoma

I am/have/hadhysterectomy

I am/have/hadinvasive bladder cancer

I am/have/hadserum pregnancy test

I am/have/hadcarcinoma in situ

I am/have/hadoophorectomy

I am/have/hadcombination therapy

I am/have/hadluteinizing hormone

I am/have/hadhormone levels

I am/have/hadrecurrent tumor

I am/have/hadintravesical bcg therapy

I am/have/hadhormone level

I am/have/hadbilateral salpingectomy

I am/have/hadtransitional cell carcinoma of bladder

I am/have/hadcombined modality therapy

added new label for I am/have/had

more

I am looking for

I am looking forgemcitabine

I am looking forbcg vaccine

I am looking forintravesical bcg

I am looking fordocetaxel

I am looking forluteinizing hormone

I am looking forfollicle stimulating hormone

I am looking forbacillus calmette-guerin

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

A single-arm, two-stage, open-label, phase 2 study investigating the safety and efficacy of intravesical gemcitabine/docetaxel for bacillus Calmette-Guerin (BCG)-nave patients with non-muscle invasive bladder cancer (NMIBC). All participants will receive an induction course of gemcitabine/docetaxel instillations followed by maintenance instillations if initial efficacy is seen. In addition to providing initial …

bladder cancer

invasive bladder cancer

luteinizing hormone

intravesical bcg therapy

oophorectomy

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.